Mostrando ítems 1-20 de 124

      Financiación
      "Fondo Europeo de Desarrollo Regional" (ISCIII/FEDER) MS16/00085 [1]
      "Fondo Europeo de Desarrollo Regional" (ISCIII/FEDER) CD17/00212 [1]
      "Fondo Europeo de Desarrollo Regional" (ISCIII/FEDER) CP16/00085 [1]
      AECC "Junta provincial de Murcia" PI14/00067- PI14/01716- PI14/01880- PI14/00556- BA15/00093- FFIS-CC 2016-06 [1]
      Andalusian Department of Health PI-0152/2017 [1]
      Andalusian Health Service [1]
      Andalusian Public Foundation for Biosanitary Research of Eastern Andalusia Alejandro Otero (FIBAO) [1]
      Andalusian public health system biobank S2000353 [1]
      B.C.A.C. was funded through a European Community Seventh Framework Programme under grant agreement no 223175 (HEALTH-F2-2009-223175; COGS); Cancer Research UK (C1287/A10118, C1287/A10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692); the National Institutes of Health Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201), R01 grants (CA128978, CA176785, CA192393), and Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112 - the GAME-ON initiative); the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, the Breast Cancer Res. Foundation, and the Ovarian Cancer Research Fund. CIMBA genotyping was supported by National Institutes of Health grant (CA128978); the Department of Defence (W81XWH-10-1-0341); and the Breast Cancer Res. Foundation. CIMBA data management and data analysis were supported by Cancer Research UK grants C12292/A11174 and C1287/A10118. This study made use of data generated by the Wellcome Trust Case Control consortium. Functional studies were supported by the Florida Breast Cancer Foundation. A full description of funding and acknowledgments is provided in Supplementary Note 1. [1]
      Biomedical Research Networking Center-CIBER de Epidemiologia y Salud Publica (CIBERESP) [1]
      Cancer Epidemiological Surveillance Subprogram (VICA) from the Instituto de Salud Carlos III, Madrid, Spain [1]
      Catalan Institute of Oncology -ICO (Spain) [1]
      CIBER de Epidemiologia y Salud Publica (CIBERESP) [1]
      CIBER Epidemiologia y Salud pública [1]
      Consejería de Innovación, Junta de Andalucía [P09-CTS-5488] [1]
      Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades CV20-29480 [1]
      Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiologia y Salud Publica) [1]
      Det Frie Forskningsrad (DFF) 30531 [1]
      Este trabajo ha sido financiado por proyectos de investigación de la Comisión Europea (7th. Frame Work, CONTAMED Nº: 212502) y de la Consejería de Salud de la Junta de Andalucía (SAS-0133/2007). [1]
      Este trabajo ha sido subvencionado, en parte, por los proyectos FIS 00/543 y Unión Europea QLK4-1999-01422 [1]